Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.650
-0.001 (-0.06%)
At close: Jun 5, 2025, 4:00 PM
1.580
-0.070 (-4.24%)
After-hours: Jun 5, 2025, 7:17 PM EDT
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $16.79 million as of June 5, 2025. Its market cap has decreased by -13.02% in one year.
Market Cap
16.79M
Enterprise Value
11.40M
1-Year Change
-13.02%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $16.79M, a decrease of -85.44%. That is a compound annual growth rate of -23.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 16.60M | -19.42% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.33B |
| Johnson & Johnson | 372.75B |
| AbbVie | 330.39B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 273.98B |
| Abbott Laboratories | 230.39B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |